Nautilus Biotechnology Inc (NAUT)

Nautilus Biotechnology Inc (NAUT) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $412M; returns 1 day +24.6%, 1 week +57.3%, 1 year +123.4%.

Nautilus Biotechnology, Inc. (NAUT) is a pre-revenue biotechnology company developing a novel single-molecule proteomics platform designed to map the human proteome at unprecedented scale and throughput, akin to next-generation sequencing in genomics. The platform aims to enable proteomics applications in drug discovery, diagnostics, and personalized medicine.

Groups NAUT belongs to

• Biotechnology
• Life Sciences
• Life Sciences Tools & Services
• Clinical Stage
• Healthcare
• Precision Medicine
• Single-Cell Analysis
• R&D
• Healthcare Technology

NAUT financial model: income statement, cash flow and balance sheet